DeeperDive is a beta AI feature. Refer to full articles for the facts. The six guests – including prominent economists, a political analyst, a popular YouTube podcast host and senior journalists – ...

Eli Lilly is paying $100 million upfront (PDF) for the right to develop CSL’s phase 3-stage IL-6 antibody that had previously been explored for organ transplant rejection. Australia-based CSL picked ...

The Wisconsin Policy Forum will host a panel discussion Tuesday about the location of new data centers in Wisconsin. Microsoft is planning to build 15 additional data centers in Racine County. The ...

A spoiler-filled discussion of episode 6 of the Apple TV sci-fi series. A spoiler-filled discussion of episode 6 of the Apple TV sci-fi series. is an entertainment editor covering streaming, virtual ...

Compelling results set new clinical standard in generalized myasthenia gravis (gMG), increasing confidence in the Company’s registrational KYSA-6 Phase 3 MG trial 100% of patients achieved clinically ...

HONG KONG, Oct. 16, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) today announced that the groundbreaking results from the registrational Phase III AK112-306/HARMONi-6 study of ivonescimab have been ...

Southern New Hampshire University (SNHU) announced the following students were named to the summer 2025 President’s List. The summer terms run from May to August. Full-time undergraduate students who ...

NORTH CHICAGO, Ill., Sept. 3, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced updated results from the Phase 2 EPCORE ® NHL-6 trial (NCT05451810) evaluating the feasibility of dosing and monitoring ...

(RTTNews) - AbbVie (ABBV) Wednesday reported updated results from the Phase 2 EPCORE NHL-6 study evaluating the feasibility of outpatient monitoring of epcoritamab in patients with relapsed/refractory ...